In a review by Wiseman, 96% of the patient with DCL had been exposed to either of these two classes of chemotherapeutics during conditioning and 47% had cytogenetic abnormalities consistent with t-AML including −7 and MLL gene rearrangements [6, 10, 11]. This evidence concerns the gene KMT2A and acute myeloid leukemia.